HM
ABUS icon

HealthCor Management’s Arbutus Biopharma ABUS Stock Holding History

HealthCor Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000,000
Closed -$6.88M – 40
2016
Q3 		$6.88M Sell
2,000,000
-258,300
-11% -$1.01M 0.42% 31
2016
Q2 		$7.86M Buy
2,258,300
+29,000
+1% +$123K 0.43% 38
2016
Q1 		$9.21M Buy
2,229,300
+40,100
+2% +$143K 0.52% 34
2015
Q4 		$9.74M Buy
2,189,200
+39,200
+2% +$215K 0.59% 32
2015
Q3 		$13.1M Buy
2,150,000
+425,000
+25% +$3.77M 0.74% 31
2015
Q2 		$20.5M Buy
1,725,000
+1,006,200
+140% +$15.3M 1.03% 31
2015
Q1 		$12.6M Buy
+718,800
New +$14.7M 0.6% 42

Other funds holding ABUS

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return